Your browser doesn't support javascript.
loading
N-Terminal polyubiquitination of the ARF tumor suppressor, a natural lysine-less protein.
Kuo, Mei-Ling; den Besten, Willem; Sherr, Charles J.
Affiliation
  • Kuo ML; Howard Hughes Medical Institute, Department of Genetics and Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Cell Cycle ; 3(11): 1367-9, 2004 Nov.
Article de En | MEDLINE | ID: mdl-15467472
ABSTRACT
Ubiquitin-dependent proteolysis by proteasomes generally depends upon the conjugation of polyubiquitin chains to lysine epsilon-NH(2) groups within the targeted proteins. However, engineered lysine-less mutants of certain viral and cellular proteins can undergo polyubiquitination at their N-termini. Is N-terminal polyubiquitination a physiologic process, and how many cellular proteins can be targeted for proteasomal degradation through this mechanism? Recent work indicates that the turnover of the endogenous lysine-less human ARF tumor suppressor protein and its mouse Arf counterpart (containing a single, non-conserved lysine residue) is regulated in this manner.
Sujet(s)
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maturation post-traductionnelle des protéines / Inhibiteur p16 de kinase cycline-dépendante / Polyubiquitine Langue: En Journal: Cell Cycle Année: 2004 Type de document: Article Pays d'affiliation: États-Unis d'Amérique
Recherche sur Google
Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maturation post-traductionnelle des protéines / Inhibiteur p16 de kinase cycline-dépendante / Polyubiquitine Langue: En Journal: Cell Cycle Année: 2004 Type de document: Article Pays d'affiliation: États-Unis d'Amérique